Substance Use Disorders News

In January, the U.S. Drug Enforcement Administration announced new rules to make permanent expanded telehealth access that was established during the COVID-19 pandemic, particularly for individuals on controlled medications.

Nonfatal fentanyl exposures increased nearly 1,200% among children and adolescents from 2015 to 2023, according to findings published in The American Journal of Drug and Alcohol Abuse.

Individuals in Canada who received hospital care for hallucinogen use had greater 5-year mortality risk, especially from suicide, compared with the general population, according to a study published in Canadian Medical Association Journal.

Using etrasimod with opioids or antidepressants did not increase risk for serotonin syndrome-associated adverse events among patients with ulcerative colitis, according to a study published in United European Gastroenterology Journal.

The trajectory of sports gambling over the past several years exhibits strong ties to trends related to alcohol use disorders, results from a cross-sectional survey study showed.

The Prospera SCS system for pain management relieved pain, improved sleep and reduced opioid use at 24 months, according to interim results of the BENEFIT-03 study.

An analysis of recent drug use in the United States revealed unexpected trends in substances being used in tandem with fentanyl, according to an expert.

The American Society of Anesthesiologists released new guidance on the safe use of ketamine for nonanesthesia purposes, such as the treatment of mental health disorders, according to an organization press release.

The FDA has approved label changes for once-monthly Sublocade, helping to reduce possible barriers to treatment initiation for opioid use disorder and speed up availability of treatment, according to a press release from the manufacturer.